Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)

Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: HEK 293 cells
  • Purity: > 98% SDS-PAGE
  • Endotoxin level:
  • Active: Yes
  • Suitable for: SDS-PAGE, ELISA

You may also be interested in

Anti-Dopamine Receptor D3/DRD3 antibody (ab40655)
Product image
Anti-LYVE1 antibody [EPR21857] (ab219556)
Product image
Anti-EFHC1 antibody (ab204080)
Product image
Recombinant Human SREBP2 protein (ab114215)

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.

    pH: 7.4
    Constituents: 5% Trehalose, 0.61% Tris, Glycine, L-Arginine, Sodium chloride

    This product is an active protein and may elicit a biological response in vivo, handle with caution.

  • Reconstitution
    Lyophilized from 0.22 µm filtered solution. Reconstitute with sterile deionized water to a concentration of 200 µg/ml.

Images

  • Functional Studies - Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)
    Functional Studies - Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)

    Recombinant human TNF alpha protein (Active) (ab155699) at 2 µg/mL (100 µL/well) can bind ab174046 with a linear range of 0.2-6 ng/mL.

  • SDS-PAGE - Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)
    SDS-PAGE - Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)

    SDS-PAGE analysis ofab174046 in reducing conditions. Gel stained overnight with Coomassie Blue. DTT-reduced Protein migrates as 50-60 kDa due to different glycosylation.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Recombinant human TNF Receptor I protein (Fc Chimera Active) (ab174046)

  •  
  • Recombinant Mouse TNF Receptor I protein (ab185837)

    Applications: HPLC, SDS-PAGE

  •  
  • Product image

    Recombinant Human TNF Receptor I protein (denatured) (ab134554)

    Applications: SDS-PAGE

  •  
  • Product image

    Recombinant human TNF Receptor I protein (Active) (ab224647)

    Applications: FuncS, SDS-PAGE

  •  
  • Product image

    Recombinant human TNF Receptor I protein (ab157278)

    Applications: FuncS, SDS-PAGE

  •  
  • Product image

    Recombinant Human TNF Receptor I protein (His tag) (ab219229)

    Applications: SDS-PAGE

Clear all

Recently viewed products

  •  
  • Product image

    Rabbit Anti-Goat IgG H&L (Alexa Fluor® 647) preadsorbed (ab150147)

  •  
  • Product image

    Donkey Anti-Rabbit IgG H&L (TRITC) preadsorbed (ab7080)

  •  
  • Goat Anti-Guinea pig IgG H&L (FITC) preadsorbed (ab7135)

  •  
  • Product image

    Mitochondrial Hydroxyl Radical Detection Assay Kit (ab219931)

  •  
  • Product image

    Human ACADVL (VLCAD) knockout HEK-293T cell lysate (ab257332)

  •  
  • Product image

    Recombinant human IKK beta protein (Active) (ab217831)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.